Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-009349
Filing Date
2020-02-13
Accepted
2020-02-13 17:21:28
Documents
1
Period of Report
2020-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7977
  Complete submission text file 0001209191-20-009349.txt   9637
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Issuer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139
Business Address
Stamoulis Christiana (Reporting) CIK: 0001502917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12400 | Film No.: 20612118